DeepMed Research

Rabin Medical Center

🇮🇱Israel

Country: 🇮🇱Israel

Ownership: Private

Established: 1936-01-01

Employees: -

Market Cap: -

Website: https://rabin-medical.org

Clinical Trials

Short-term Antibiotic Treatment for Unexplained Fever in Solid Cancer Patients With Febrile Neutropenia

Not Applicable

Withdrawn

Conditions: Febrile Neutropenia

Interventions: Other: Early antibiotic discontinuation
Other: Usual practice

First Posted Date: 2011-10-12

Last Posted Date: 2013-06-07

Lead Sponsor: Rabin Medical Center

Registration Number: NCT01450241

Locations: 🇮🇱
Rabin Medical Center, Beilinson Hospital, Petah Tikvah, Israel

Use of Beta-agonists in Stable Severe Congestive Heart Failure

Not Applicable

Conditions: Ischemic Cardiomyopathy
Non-ischemic Cardiomyopathy
Heart Failure

Interventions: Drug: Salbutamol

First Posted Date: 2011-10-05

Last Posted Date: 2011-10-05

Lead Sponsor: Rabin Medical Center

Target Recruit Count: 30

Registration Number: NCT01447069

Locations: 🇮🇱
Rabin medical center, Petah Tikva, Israel

Dronaderone to Prevent Recurrent Implantable Cardioverter Defibrillator (ICD) Shocks

Not Applicable

Conditions: ICD
ICD SHOCKS
DRONEDARONE

Interventions: Drug: Dronedarone arm
Drug: Dronedarone

First Posted Date: 2011-09-08

Last Posted Date: 2011-09-08

Lead Sponsor: Rabin Medical Center

Target Recruit Count: 20

Registration Number: NCT01430806

Safety and Efficacy of Inhaled Alpha-1 Antitrypsin in Preventing Bronchiolitis Obliterable Syndrome in Lung Transplant Recipients

Phase 2

Conditions: Lung Transplantation
Bronchiolitis Obliterable Syndrome

Interventions: Drug: Alpha -1 Antitrypsin
Drug: Alpha-1 Antitrypsin
Drug: AAT

First Posted Date: 2011-07-14

Last Posted Date: 2011-07-14

Lead Sponsor: Rabin Medical Center

Target Recruit Count: 40

Registration Number: NCT01394835

Cannabidiol for Graft Versus Host Disease (GVHD) Prophylaxis in Allogeneic Stem Cell Transplantation

Phase 1

Conditions: Graft Versus Host Disease

Interventions: Drug: Oral Cannabidiol

First Posted Date: 2011-06-29

Last Posted Date: 2015-06-19

Lead Sponsor: Rabin Medical Center

Target Recruit Count: 30

Registration Number: NCT01385124

Locations: 🇮🇱
Davidoff Cancer Center, Beilin hospital, Rabin medical center, Petach Tikva, Israel

Pilot Study of Hematopoietic Stem Cell Transplantation From Two Matched Sibling Donors in Treating Patients With Poor Prognosis Acute Leukemia and Advanced Lymphoproliferative Malignancies

Phase 1

Conditions: Relapsed and Refractory Acute Leukemia

Interventions: Biological: Double matched sibling transplantation

First Posted Date: 2011-06-29

Last Posted Date: 2011-11-16

Lead Sponsor: Rabin Medical Center

Target Recruit Count: 10

Registration Number: NCT01385072

Locations: 🇮🇱
Davidoff Cancer Center, Beilin hospital, Rabin medical center, Petach Tikva, Israel

Acute Effect of Sildenafil on Exercise Tolerance and Functional Capacity in COPD, IPF and Post Pneumonectomy Patients

Phase 4

Conditions: Chronic Obstructive Pulmonary Disease
Idiopathic Pulmonary Fibrosis

Interventions: Drug: Sildenafil

First Posted Date: 2011-06-27

Last Posted Date: 2012-11-15

Lead Sponsor: Rabin Medical Center

Target Recruit Count: 60

Registration Number: NCT01382368

Locations: 🇮🇱
Pulmonary Institute, Rabin Medical Center, Beilinson Hospital, Petach Tikva, Israel

Use of Azithromycin as Immunomodulatory Therapy in Grave&Apos;s Orbitopathy

Phase 1

Withdrawn

Conditions: Graves Ophthalmopathy

Interventions: Drug: Azithromycin

First Posted Date: 2011-06-23

Last Posted Date: 2017-04-27

Lead Sponsor: Rabin Medical Center

Registration Number: NCT01379196

Thrombocytopathy in Gaucher Disease Patients

Conditions: Gaucher Disease
Thrombocytopathy

First Posted Date: 2011-04-28

Last Posted Date: 2016-10-28

Lead Sponsor: Rabin Medical Center

Target Recruit Count: 70

Registration Number: NCT01344096

Locations: 🇮🇱
Rabin Medical Center, Petach Tikva, Israel
🇮🇱
Rambam Medical Center, Haifa, Israel

Treatment of Pemphigus Patients With Rituximab 1000mgX2 and Assessment of Immune Status Via Cylex

Not Applicable

Conditions: Pemphigus

Interventions: Drug: Rituximab

First Posted Date: 2011-04-19

Last Posted Date: 2011-05-02

Lead Sponsor: Rabin Medical Center

Target Recruit Count: 10

Registration Number: NCT01338103

Locations: 🇮🇱
Bullous diseases clinic, Department of dermatology, Rabin Medical Center, Petah Tiqva, Israel

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy